Riskpilot← Back to searchSign inGet full accessNORINNOVA FORVALTNING AS
ASActiveOrg 991381473Sykehusvegen 23, 9019 TromsøFund management activities · NACE 6630Est. 20071 employees
Revenue 2024
NOK 3,1M
-40% vs 2023
EBITDA margin
50.2%
-24% vs 2023
Equity ratio
88.1%
Financial strength
Net profit 2024
NOK 328K
-84% vs 2023
| Revenue | NOK 3,1M | -40% |
| EBITDA | NOK 1,5M | -24% |
| Net profit | NOK 328K | -84% |
| Total assets | NOK 4,8M | -5% |
| Equity | NOK 4,2M | +8% |
| Employees | 1 | — |
Legal name
NORINNOVA FORVALTNING AS
Org number
991381473
Legal form
Aksjeselskap
NACE code
6630 · Fund management activities
Founded
25. juni 2007
Share capital
NOK 170 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Karl johan jakola
Company purpose
Drive aktiv investeringsrådgivning og forvaltning av porteføljeselskap for investeringsfond. Selskapet kan investere i porteføljeselskap og annen form for kapitalplasseringer, herunder kjøp og salg av aksjer, samt virksomhet som naturlig hører sammen med dette.
Address
Sykehusvegen 23, 9019 Tromsø
Phone
+4790559001
Email
info@norwayexports.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 598 | 2 382 | 1 192 | 5 089 | 3 058 |
| Staff expenses | −2 455 | −1 314 | −0 | −2 601 | −1 095 |
| EBITDA | −1 421 | 631 | −682 | 2 024 | 1 537 |
| Depreciation & amort. | −5 | −3 | −0 | −0 | −0 |
| EBIT | −1 426 | 628 | −682 | 2 024 | 1 537 |
| Net financials | 42 | 61 | 6 | 57 | −856 |
| Profit before tax | −1 384 | 690 | −676 | 2 081 | 680 |
| Tax | −55 | −0 | −0 | 35 | 352 |
| Net profit | −1 328 | 690 | −676 | 2 046 | 328 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 777 | 3 426 | 3 276 | 5 030 | 4 781 |
| Equity | 1 814 | 2 503 | 1 837 | 3 883 | 4 212 |
| Long-term debt | 0 | 0 | 990 | 0 | 0 |
| Short-term debt | 350 | 922 | 448 | 1 147 | 569 |
| Total debt | 350 | 922 | 1 438 | 1 147 | 569 |
EBITDA margin
50.2%
This company
15.8%
Market median
+218% vs market
20202024
Equity ratio
88.1%
This company
38.2%
Market median
+131% vs market
20202024
Return on equity
7.8%
This company
18.4%
Market median
-58% vs market
20202024
Net profit margin
10.7%
This company
8.1%
Market median
+32% vs market
20202024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MR Deputy Member | Deputy Member | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2024 | |
| Former (1) | ||
| Chairman | 2017 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 30% | 30% | 2023 | |
| Company | 19.05% | 19.05% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Risagryn As
NORINNOVA FORVALTNING AS Board members of NORINNOVA FORVALTNING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Margareth Rørvik | Deputy Member | 0 companies |
| Karl Johan Jakola | Chairman | 0 companies |
| Jan Kristoffersen | Chairman | 0 companies |